Viatris (VTRS) Long-Term Investments (2020)
Viatris (VTRS) posted Long-Term Investments of $25.0 million for Q4 2020.
Powered by 
Analysis
Viatris (VTRS) Long-Term Investments (2020) Analysis & Trends
Viatris has reported Long-Term Investments for 1 years, with the latest figure at $25.0 million in Q4 2020.
- On a quarterly basis, Long-Term Investments changed N/A year-over-year to $25.0 million in Q4 2020; TTM through Dec 2020 was $25.0 million, a N/A change from a year earlier, with the FY2020 full-year figure at $25.0 million, changed N/A from the prior year.
- Long-Term Investments was $25.0 million for Q4 2020 at Viatris.
- The five-year high for Long-Term Investments was $25.0 million in Q4 2020, with the low at $25.0 million in Q4 2020.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Long-Term Investments (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 42.84 Bn | 39.19 Bn | 2.15 Bn | - |
| 2 | Viatris | 19.13 Bn | 18.24 Bn | 1.46 Bn | - |
| 3 | Dr Reddys Laboratories | 9.91 Bn | 9.74 Bn | 396.53 Mn | 848.23 Mn |
| 4 | Amneal Pharmaceuticals | 5.51 Bn | 5.38 Bn | 334.51 Mn | - |
| 5 | Bausch Health Companies | 2.30 Bn | 464.50 Mn | 2.10 Bn | - |
| 6 | Alvotech | 1.50 Bn | 1.36 Bn | 2.56 Mn | - |
| 7 | Ani Pharmaceuticals | 1.49 Bn | 1.13 Bn | 165.89 Mn | - |
| 8 | Amphastar Pharmaceuticals | 1.00 Bn | 714.13 Mn | 93.47 Mn | 16.30 Mn |
| 9 | Fennec Pharmaceuticals | 402.10 Mn | 360.85 Mn | 17.15 Mn | - |
| 10 | RedHill Biopharma | 178.35 Mn | 178.35 Mn | - | 12.05 Mn |